Your browser is no longer supported. Please, upgrade your browser.
Settings
PBYI Puma Biotechnology, Inc. daily Stock Chart
PBYI [NASD]
Puma Biotechnology, Inc.
Index- P/E- EPS (ttm)-8.16 Insider Own11.60% Shs Outstand34.17M Perf Week4.35%
Market Cap1.31B Forward P/E- EPS next Y-7.18 Insider Trans-0.52% Shs Float31.67M Perf Month18.91%
Income-265.10M PEG- EPS next Q-1.92 Inst Own97.00% Short Float17.93% Perf Quarter-9.76%
Sales- P/S- EPS this Y-57.50% Inst Trans18.35% Short Ratio7.97 Perf Half Y-23.44%
Book/sh2.80 P/B13.70 EPS next Y11.60% ROA-141.40% Target Price86.33 Perf Year-17.70%
Cash/sh3.19 P/C12.03 EPS next 5Y- ROE-180.00% 52W Range19.74 - 73.27 Perf YTD24.92%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-47.66% Beta0.43
Dividend %- Quick Ratio3.10 Sales past 5Y- Gross Margin- 52W Low94.28% ATR2.20
Employees156 Current Ratio3.10 Sales Q/Q- Oper. Margin- RSI (14)60.01 Volatility6.34% 6.29%
OptionableYes Debt/Eq0.00 EPS Q/Q-8.20% Profit Margin- Rel Volume1.54 Prev Close40.25
ShortableYes LT Debt/Eq0.00 EarningsFeb 27 AMC Payout- Avg Volume712.93K Price38.35
Recom1.90 SMA2011.05% SMA5011.34% SMA200-8.16% Volume1,099,007 Change-4.72%
Sep-22-16Reiterated Credit Suisse Outperform $54 → $111
Sep-21-16Upgrade Stifel Hold → Buy $61 → $88
Mar-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $103 → $36
Jan-21-16Initiated Credit Suisse Outperform
Dec-14-15Upgrade Citigroup Neutral → Buy
Sep-03-15Initiated Citigroup Neutral
Aug-27-15Initiated JP Morgan Overweight $122
Jan-23-15Initiated RBC Capital Mkts Outperform $282
Aug-19-14Resumed Stifel Hold
Jul-23-14Reiterated UBS Buy $125 → $325
Dec-19-13Reiterated UBS Buy $61 → $125
Dec-19-13Downgrade Stifel Buy → Hold
Jul-22-13Reiterated Stifel Buy $42 → $64
Jun-03-13Reiterated UBS Buy $35 → $49
Mar-25-13Reiterated Stifel Buy $32 → $42
Mar-20-13Reiterated UBS Buy $27 → $35
Feb-14-17 04:15PM  Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference Business Wire
Feb-08-17 04:15PM  Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference Business Wire +10.04%
Feb-03-17 09:19AM  Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?
Jan-09-17 06:07PM  Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
04:55PM  Newman Ferrara LLP Announces Corporate Governance Investigation of Puma Biotechnology, Inc. - PBYI Business Wire
Jan-06-17 02:13PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
08:15AM  Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients Business Wire
Jan-05-17 01:04PM  PUMA BIOTECHNOLOGY, INC. Financials
Jan-03-17 04:15PM  Puma Biotechnology to Present at J.P. Morgan Healthcare Conference Business Wire
Dec-19-16 04:27PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St
04:15PM  Puma Biotechnology to Move Stock Exchange Listing to Nasdaq Business Wire
Dec-08-16 12:38PM  Puma Cancer Drug Suffers 'Approvability Risk' On Extreme Side Effect -8.42%
08:46AM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
08:35AM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
Dec-07-16 06:21PM  Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
06:07PM  Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium Business Wire
07:00AM  Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards
Dec-06-16 06:44PM  CORRECTING and REPLACING Puma Biotechnology Initiates a Managed Access Program for PB272 (Neratinib) Outside the United States Business Wire
Nov-30-16 09:33AM  Why Did Puma Biotechnology Dilute Shareholders? at Motley Fool
Nov-28-16 02:11PM  Puma Biotechnology, Inc. :PBYI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -5.31%
Nov-22-16 08:12AM  Shareholder Dilution: What Investors Need to Know at Motley Fool
Nov-19-16 10:15AM  4 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Nov-15-16 03:57PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Puma Biotechnology, Inc. and Advises Investors with Losses to Contact the Firm Business Wire +7.36%
03:11PM  Heres Why The Puma Biotechnology Inc (PBYI) Pullback Might Be A Buy-In Opportunity at Insider Monkey
03:10PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc. (PBYI) PR Newswire
01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI PR Newswire
Nov-14-16 07:16PM  Puma Biotechnology Announces Presentations of Investigational Data at the San Antonio Breast Cancer Symposium (SABCS) Business Wire -20.44%
05:36PM  What Caused Puma Biotechnology's Shares to Tumble 20.5% Today at Motley Fool
04:37PM  Credit Suisse Says Gr3 Diarrhea Still A Concern For Puma Biotech, But Pullback Is Overdone
01:13PM  Puma Biotechnology falls more than 20% at CNBC
11:25AM  Puma Bio Falls on Escalating Concerns About Diarrhea Risk With Breast Cancer Drug
Nov-11-16 10:07PM  Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI PR Newswire
Nov-10-16 07:50AM  Puma (PBYI) Posts Wider Loss in Q3, Neratinib in Focus
Nov-09-16 05:29PM  Puma Biotech reports 3Q loss +16.25%
05:24PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:15PM  Puma Biotechnology Reports Third Quarter 2016 Financial Results Business Wire
04:11PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 10-Q, Quarterly Report
Nov-03-16 06:24PM  Puma Biotechnology (PBYI) Q3 Earnings: What's in Store? -9.31%
Oct-31-16 04:15PM  Puma Biotechnology to Present at Credit Suisse Healthcare Conference Business Wire
11:38AM  Lifshitz & Miller Law Firm Announces Investigation of Electronics for Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., and TG Therapeutics, Inc. PR Newswire
Oct-28-16 10:07PM  PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. PBYI Business Wire
Oct-25-16 11:45AM  Puma Biotechnology Closes $172 Million Public Offering of Common Stock Business Wire
Oct-23-16 10:15AM  4 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Oct-21-16 05:04PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:34PM  Puma Biotech, Which Had Weak Demand For A Secondary Offering, Is Also Part Of The SEC Tick Size Pilot Program
08:31AM  Puma Biotechnology Announces Underwriters Full Exercise of Option to Purchase Additional Shares Business Wire
Oct-20-16 08:40AM  Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
04:43AM  Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (PTCT), Puma Biotechnology Inc (PBYI) and Nektar Therapeutics (NKTR) at Insider Monkey
Oct-19-16 11:18PM  Puma Biotechnology Prices Public Offering of Common Stock Business Wire -18.90%
03:43PM  Puma Biotech Gears Up for Secondary Offering
01:01PM  Why Puma Biotechnology Inc. Sold Lower Today at Motley Fool
09:07AM  Why Traders Are Watching Manhattan Associates, Meridian Bioscience, Puma Biotechnology, Tesla and More at Insider Monkey
Oct-18-16 05:53PM  Puma Biotechnology (PBYI) Stock Down in After-Hours Trading on Public Offering
04:36PM  Puma Biotech shares slide on secondary stock offering at MarketWatch
04:15PM  Puma Biotechnology Announces Proposed Public Offering of Common Stock Business Wire
Oct-17-16 06:04AM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
Oct-14-16 10:07PM  PUMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. PBYI Business Wire
Oct-12-16 02:52PM  Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants' Motion to Dismiss in Securities Class Action Business Wire
Oct-11-16 11:30AM  Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives PR Newswire
Oct-10-16 10:32AM  Johnson & Weaver, LLP Initiates Investigations of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. and Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Ri PR Newswire
Oct-04-16 10:15AM  Lawsuit for Investors in shares of Puma Biotechnology Inc (NYSE:PBYI) against Directors announced by Shareholders Foundation GlobeNewswire
Sep-30-16 09:13AM  5 Top Performing Stocks of the Best ETF of Q3
09:10AM  SEC Issues Charges Over Biotech Insider Activity
07:00AM  Biotech Stock Mailbag: Dynavax, Puma, Ariad
Sep-29-16 04:05PM  SEC charges former Puma Biotech employee with insider trading Reuters
Sep-27-16 11:49AM  Momentum Carries Lululemon Lower, Pushes Biotech Names Higher at Forbes
Sep-25-16 10:45AM  6 Biotech and Biohealth Analyst Picks for 50% to 150% Upside at 24/7 Wall St.
10:20AM  Could Puma Biotech Double After This FDA Approval? at 24/7 Wall St.
Sep-22-16 04:31PM  Puma Races To Eight-Month High On Breast Cancer Drug Success
03:42PM  Greater Expectations For Puma Technology Boost Credit Suisse Target Price To $111
11:50AM  Why Key Analyst Sees Puma Biotech Practically Doubling at 24/7 Wall St.
10:56AM  Puma Biotechnology Shares Leap Forward
10:11AM  Puma Biotechnology: That's Some Target Increase!!! at Barrons.com
09:05AM  Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Bed Beth & Beyond, Puma Biotechnology, SeaWorld and More at 24/7 Wall St.
Sep-21-16 03:38PM  4 health-care stocks to watch at MarketWatch
11:01AM  3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions at Motley Fool
10:51AM  Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
07:22AM  Puma Biotech. upgraded by Stifel
05:45AM  Puma Biotechnology (PBYI) Shares March Higher, Can It Continue?
Sep-20-16 04:52PM  Biotechs Still Hot As Sarepta Drug Approval Provides A Shot In Arm +10.53%
03:01PM  Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy at Motley Fool
02:27PM  Why Puma Biotechnology Inc Roared Higher Today at Motley Fool
01:49PM  Biotechs Still Hot As Sarepta Drug Approval Provides A Shot In Arm
01:13PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
12:29PM  Heres Why These Five Stocks Are on the Move Today at Insider Monkey
11:35AM  Why Puma Biotechnology (PBYI) Stock Is Surging Today
11:15AM  Puma Biotech Rises on Key FDA Approval at 24/7 Wall St.
09:51AM  Puma Biotechnology: Sarepta Isn't the Only Biotech Getting a Boost From the FDA at Barrons.com
08:01AM  Puma Biotechnology Announces U.S. FDA Acceptance of New Drug Application for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Sep-19-16 03:00PM  After Losing Medivation, Who Is Gilead Going After Next? at Forbes
Sep-13-16 03:14PM  Puma Biotechnology, Inc. :PBYI-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
10:13AM  Puma Biotechnology (PBYI): Moving Average Crossover Alert
Sep-06-16 04:00PM  3 Hottest Cancer Biotech Acquisition Targets After Medivation at Forbes
Aug-23-16 12:07PM  4 Biotech Stock Charts You Must See
09:37AM  Puma (PBYI) Neratinib's Application Validated in EU, Stock Up
Aug-22-16 04:20PM  PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events +9.10%
02:57PM  After Medivation, These 6 Biotech Stocks Could Be M&A Targets Next at Barrons.com
08:05AM  Puma Biotechnology Announces European Medicines Agency Validation of Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europe Business Wire
Aug-19-16 09:30AM  The Zacks Analyst Blog Highlights: Apple, Exact Sciences, Amkor Technology, Puma Biotechnology and Chemours
Aug-18-16 02:39PM  4 Biggest Winners from This Earnings Season
Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) and PB272 (neratinib (intravenous) that are in Phase-III and Phase-II clinical trials for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, and HER2 mutation-positive solid tumors. The company is also developing PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHARNAS ROBERTFeb 01Sale31.833,00895,75526,453Feb 02 05:43 PM
Lo StevenChief Commercial OfficerJan 20Sale33.242,29076,10829,210Jan 24 05:56 PM
EYLER CHARLES RSEE REMARKSJan 20Sale33.2482027,2539,680Jan 24 05:53 PM
CHARNAS ROBERTJan 20Sale33.242,29376,20829,407Jan 24 05:52 PM
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJan 20Sale33.242,29376,20829,237Jan 24 05:51 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 20Sale33.2410,202339,0644,179,798Jan 24 05:49 PM
SOXL Direxion Daily Semicondct Bull 3X ETF daily Stock Chart
SOXL [NYSE]
Direxion Daily Semicondct Bull 3X ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week7.87%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month20.44%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter39.16%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.28 Perf Half Y74.89%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year262.85%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range18.35 - 70.83 Perf YTD29.32%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High4.25% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low302.40% ATR2.57
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)70.19 Volatility3.14% 3.45%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.04 Prev Close70.80
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume302.31K Price73.84
Recom- SMA209.63% SMA5018.39% SMA20066.29% Volume315,817 Change4.29%
Jan-03-17 10:53AM  Top 5 Semiconductor ETFs of 2016 at Investopedia
Dec-28-16 02:07PM  6 Best Performing Leveraged ETFs of 2016 -5.81%
Nov-22-16 09:27AM  Bull Market Here to Stay: 10 ETF Ways to Play
Oct-04-16 12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) at Investopedia
Oct-03-16 10:58AM  5 Best Performing Leveraged ETFs of September
Aug-08-16 05:09PM  How Volatility Affects 2 Popular Leveraged ETFs
Jul-22-16 08:16AM  A Rocking Russia ETF
Jul-19-16 01:35PM  Loving Leveraged Bond ETFs
Jul-18-16 01:56PM  SoftBank, ARM Deal Helps Semiconductor ETF Push Higher
Jun-30-16 01:26PM  A Brexit Boon For These Leveraged ETFs +5.45%
Jun-16-16 01:45PM  Listen To What Leveraged S&P 500 ETFs Are Saying
Jun-10-16 09:21AM  A Conservative Way To Short The S&P 500 -5.02%
May-31-16 01:59PM  Suddenly Super Semiconductor ETFs; But Is It A Home Run?
May-27-16 01:11PM  This Biotech ETF Could Be Ready To Party
May-20-16 01:52PM  Applied Materials Earnings Beat Helps Semiconductor ETFs Power Up +9.31%
01:30PM  ETF TMI: Latest ETF Launches, Transitions & Jumps
10:54AM  Monitoring Oil Services ETFs Schlumberger, Halliburton
10:51AM  If Rates Rise, Look to These Junk Bond ETFs
10:46AM  Amazon, Wal-Mart Will Lift This Retail ETF
10:40AM  Corn ETF Looks to Breakout
10:34AM  Steady Swiss ETFs Ready to Rally
08:25AM  Bank on Financial ETFs in Rising Rate Environment
08:15AM  Getting Tactical for the Long Term
May-19-16 04:26PM  41 Target Maturity Bond ETFs for Rising Rates
May-18-16 08:20AM  Dollar ETFs Look for Green
May-08-16 12:25PM  USD vs. SOXL: Comparing Leveraged Semiconductor ETFs at Investopedia
Apr-22-16 05:51AM  Gold Miner ETFs Are Having the Rally of a Lifetime and Burned Investors Are Missing It at Bloomberg
Apr-12-16 08:15AM  Leveraged Energy ETFs For Earnings Season
Apr-08-16 08:41AM  New Inverse ETFs For Bearish Sector Traders
Mar-23-16 01:45AM  How To Trade Leveraged ETFs
Mar-17-16 07:27AM  Rousseff Is A Problem For Brazil Leveraged ETF
Mar-08-16 08:11AM  Brazil ETF's Rise Stokes Volume Spike In Leveraged Counterpart -6.81%
Mar-02-16 01:58PM  These Bond ETFs Are On Fire
01:04PM  The strange ETF thats doubled this year at CNBC
Feb-26-16 03:03PM  Some Say The Gold Miners Trade Is Back
Feb-12-16 08:11AM  This Little Nugget Of An ETF Is Delivering Astounding Returns +6.61%
Feb-04-16 01:19PM  Leveraged Miners ETF Struts Its Stuff
Jan-29-16 08:34AM  Gold Miner ETFs Rake In Assets Despite Dismal Performance +13.50%
Jan-26-16 06:47AM  Traders Are Missing Out On The Right China ETFs
Jan-20-16 02:03PM  6 Inverse Leveraged ETFs Up Over 50% YTD
Jan-12-16 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear
Jan-11-16 10:18AM  6 Inverse Leveraged ETFs Soaring to Start 2016
06:14AM  Traders Aren't Displaying Much Confidence In Leveraged Gold Miner ETFs
Dec-22-15 07:56AM  Russia ETFs On The Rocks...Except For One
Dec-11-15 09:36AM  Using Leveraged Energy ETFs As Rising Rates Plays -5.88%
Dec-03-15 02:17PM  A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
Nov-23-15 01:52PM  The One Retail ETF That Isn't Disappointing
Nov-21-15 02:02PM  Russia Rally Reveals Love For Leverage
Nov-18-15 03:50PM  Gold Miners ETFs Are Getting Smoked
Nov-10-15 06:28AM  Digging Deep With Leveraged Gold Miner ETFs As Higher Rates Loom -5.44%
Nov-09-15 02:58PM  Rate Hike Odds Shine A Light On Leveraged Gold Miners ETFs
Oct-15-15 07:46AM  Here's How Traders Have Once Again Botched The Gold Miners Trade
Oct-13-15 09:30AM  The Zacks Analyst Blog Highlights: ERX,DIG,GASL,GUSH and UOP
07:15AM  How To Use Leveraged ETFs To Beat The Fed
Oct-09-15 12:06AM  Bill Gross Believes Every Asset Price Is Artificially Elevated
Oct-05-15 02:26PM  Bullish Leveraged Gold Miners ETFs Are On Fire +5.57%
Sep-28-15 03:57PM  Wild Ride For Leveraged Biotech ETFs Continues -8.34%
Sep-15-15 03:43PM  Not DUST In The Wind: Perhaps The Best Gold Miners ETF
Aug-26-15 01:02PM  Traders Are Getting It Wrong With Leveraged Emerging Markets ETFs +14.85%
Aug-21-15 02:43PM  The Right ETF For Russia Right Now -7.08%
Aug-14-15 03:29PM  Well Look At That: Gold Miners ETFs Try To Bounce Back
Aug-11-15 03:31PM  Dancing With The Devil: Looking For Bottoms With Leveraged Bull Energy ETFs -6.80%
Aug-10-15 07:03AM  Leveraged Gold Miners ETFs To Host Reverse Split Party +7.50%
Aug-07-15 05:29PM  Direxion Announces ETF Splits: 3X Bullish Gold Miners to See 1-for-10 Reverse at Barrons.com
Aug-05-15 03:42PM  For The Bold: Bearish Energy ETF Ideas
Aug-04-15 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily Gold Miners Index Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, Direxion Daily Junior Gold Miners Index Bear 3x Shares and ProShares UltraShort Gold Miners ETF - Press Releases
Jul-28-15 10:00AM  Enter the Bear: How to Win With ETFs as Chinese Stocks Tumble at TheStreet +6.23%
Jul-27-15 10:03AM  A Look Ahead: Biotech And Energy ETFs To Watch This Week
May-20-15 01:17PM  Processing a Leveraged ETF Trade Idea
Mar-30-15 02:00PM  Intel/Altera Rumor Stokes Inflows to Leveraged Chip ETF
Mar-27-15 02:16PM  Semiconductor ETFs Could See Further Pain +8.21%
Dec-17-14 03:55PM  10 Best Leveraged ETFs of 2014
Sep-15-14 12:18PM  Semiconductors Selloff After Failed Breakout
Jul-15-14 02:22PM  Big Earnings Week for This Semiconductor ETF
May-27-14 03:33PM  Leveraged ETF Roundup: Russia, India & Semiconductor Lead
May-15-14 03:47PM  How AMD's Market Share Can Rise To 30% After The MacPro Deal at Seeking Alpha
May-02-14 06:12PM  What To Expect From Qualcomm at Seeking Alpha
Apr-28-14 11:20AM  NXP's Buyback, Q1 Results And Sell Side Commentary at Seeking Alpha
Apr-25-14 03:12PM  Qualcomm's Revenue Growth Slows Amid Smartphone Saturation, Slow LTE Sales In China at Seeking Alpha
Apr-24-14 06:40PM  Remaining A Little Nervously Long Qualcomm at Seeking Alpha
Apr-22-14 04:19PM  Qualcomm Earnings Preview: Chipset And Device ASPs In Focus Amid High-End Saturation at Seeking Alpha
Apr-21-14 08:35PM  AMD: Now With Lower Risk And Greater Upside at Seeking Alpha
05:28PM  Intel Is Still Struggling In The PC And Mobile Chips Business at Seeking Alpha
Apr-17-14 04:24PM  Enterprise Storage Drives SanDisk's Q1 Results, Embedded Storage Could Follow Suit at Seeking Alpha
Apr-16-14 04:52PM  Micron Technology: Worth Between $29-33 Per Share, Strong Buy On Market Correction at Seeking Alpha
Apr-15-14 05:10PM  Enterprise Storage To Drive SanDisk's First Quarter Performance at Seeking Alpha
Apr-09-14 05:13PM  AMD: The New Puma Chip As A Catalyst In Mobile at Seeking Alpha
Apr-03-14 07:00PM  What Fund Giant Klarman Sees In Micron at Seeking Alpha
Apr-02-14 03:16PM  Why Micron Technology Might Be Able To Continue Its Absurd Growth at Seeking Alpha
Mar-28-14 03:23PM  Higher Semiconductor Spending To Drive Applied's Growth In 2014 at Seeking Alpha
Mar-20-14 02:51PM  Micron: Up And Down On The Balance Sheet Train at Seeking Alpha
Feb-28-14 05:14PM  OmniVision Technologies: Cash-Rich Apple Supplier Delivers at Seeking Alpha
Feb-27-14 02:22PM  More Growth For Qualcomm On The Way at Seeking Alpha
Feb-13-14 03:32PM  Uptick In Semiconductor Investments Drive Applied's Growth In Q1 2014 at Seeking Alpha
Feb-11-14 03:04PM  Qualcomm: A Growth Stock For Investors at Seeking Alpha
Jan-31-14 05:06PM  Micron: Fairly Valued If Not Overvalued at Seeking Alpha
Jan-23-14 04:34PM  Qualcomm: Fundamentals To Remain Bullish Through H1 2014 at Seeking Alpha
Jan-17-14 02:49PM  InvenSense: The Best Chip Stock Of The Future? at Seeking Alpha
Jan-13-14 06:27PM  Analog Devices: Accumulate Following Some Bearish Catalysts at Seeking Alpha
Jan-10-14 04:07PM  Juniper Fairly Valued If Q4 Doesn't Throw Up Any Emerging Markets Surprise at Seeking Alpha
The investment seeks daily investment results, before fees and expenses, of 300% of the performance of the PHLX Semiconductor Sector Index. The fund creates long positions by investing at least 80% of its assets in the securities that comprise the PHLX Semiconductor Sector Index and/or financial instruments that provide leveraged and unleveraged exposure to the index. The index measures the performance of the semiconductor subsector of the U.S. equity market. The fund is non-diversified.
ABCO The Advisory Board Company daily Stock Chart
ABCO [NASD]
The Advisory Board Company
Index- P/E- EPS (ttm)-1.17 Insider Own0.30% Shs Outstand41.11M Perf Week-0.74%
Market Cap1.92B Forward P/E24.44 EPS next Y1.91 Insider Trans-37.65% Shs Float39.58M Perf Month9.25%
Income-50.50M PEG- EPS next Q0.56 Inst Own- Short Float7.86% Perf Quarter30.67%
Sales803.20M P/S2.39 EPS this Y17.20% Inst Trans4.30% Short Ratio4.62 Perf Half Y12.17%
Book/sh11.74 P/B3.97 EPS next Y8.04% ROA-2.60% Target Price44.86 Perf Year26.87%
Cash/sh- P/C- EPS next 5Y13.48% ROE-11.30% 52W Range18.87 - 51.23 Perf YTD40.30%
Dividend- P/FCF32.34 EPS past 5Y-35.60% ROI-6.90% 52W High-8.94% Beta1.16
Dividend %- Quick Ratio1.00 Sales past 5Y22.10% Gross Margin50.20% 52W Low147.22% ATR1.23
Employees3500 Current Ratio1.00 Sales Q/Q0.10% Oper. Margin-5.00% RSI (14)68.08 Volatility1.87% 2.49%
OptionableYes Debt/Eq1.19 EPS Q/Q5486.00% Profit Margin-6.30% Rel Volume0.75 Prev Close46.15
ShortableYes LT Debt/Eq1.11 EarningsFeb 28 AMC Payout- Avg Volume673.08K Price46.65
Recom2.10 SMA201.39% SMA5018.25% SMA20020.92% Volume503,113 Change1.08%
Feb-17-17Downgrade JP Morgan Overweight → Neutral
Jan-31-17Reiterated Stifel Hold $38 → $47
Jan-13-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-16Downgrade BofA/Merrill Buy → Underperform
Nov-02-16Reiterated Stifel Hold $45 → $43
Sep-30-16Reiterated Barclays Overweight $44 → $50
Jul-28-16Upgrade Craig Hallum Hold → Buy
Jul-28-16Reiterated FBR Capital Mkt Perform $35 → $37
Jul-19-16Downgrade Raymond James Outperform → Mkt Perform
Jun-20-16Initiated Credit Suisse Outperform
May-06-16Reiterated FBR Capital Mkt Perform $40 → $35
Apr-18-16Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-25-16Upgrade Deutsche Bank Hold → Buy $53 → $43
Feb-24-16Downgrade Stifel Buy → Hold
Feb-24-16Downgrade Robert W. Baird Outperform → Neutral $60 → $40
Feb-24-16Downgrade FBR Capital Outperform → Mkt Perform $55 → $40
Feb-24-16Downgrade Craig Hallum Buy → Hold
Feb-24-16Downgrade Cantor Fitzgerald Buy → Hold
Feb-24-16Downgrade Avondale Mkt Outperform → Mkt Perform
Nov-17-15Initiated JP Morgan Overweight $64
Feb-17-17 02:54PM  JPMorgan Doesn't Advise Buying Advisory Board, Despite 'Strategic Alternative' Talk
08:05AM  Analysts' Actions -- Arista, Capital One, Avis, Workday and More
07:30AM  Advisory Board downgraded by JP Morgan
Feb-09-17 04:36PM  These top 20 D.C.-area employers have most at stake in H-1B visa overhaul at bizjournals.com
Feb-08-17 12:43PM  [2/8] This Weeks Earnings Revisions Movers - Tech and Consumer Discretionary Lead
Feb-06-17 03:59PM  Activist-Pressured Advisory Board Launches Strategic Review
02:03PM  Advisory Board confirms it is evaluating a potential sale at bizjournals.com
08:35AM  ADVISORY BOARD CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  The Advisory Board Company Announces Exploration of Strategic Alternatives PR Newswire
Feb-03-17 09:13AM  The Market In 5 Minutes: Amazon Lower, Payrolls Higher
08:20AM  Report: Advisory Board interviewing banks for potential sale at bizjournals.com
Feb-02-17 02:47PM  Advisory Board Said to Interview Banks About Possible Sale
Feb-01-17 11:30AM  The Advisory Board Company to Report Fourth Quarter and Year-end Financial Results After Market Close on February 28, 2017 PR Newswire
09:56AM  McAuliffe confirms anchor lease with Nestlé in Rosslyn at bizjournals.com
Jan-28-17 12:01AM  [$$] Barron's Roundtable, Part 3: Digging Into the Details at Barrons.com
Jan-17-17 04:17PM  Paul Singer's Elliott Management Takes 8.3% Stake in Advisory Board at Investopedia
03:18PM  Advisory Board just laid off more than 200 people. What does this mean for its $60M in tax breaks? at bizjournals.com
01:27PM  Elliott 'Strategic Initiative' Effort at NRG Could Lead to Asset Sales, Buyout
Jan-13-17 10:39AM  Advisory Board Company (ABCO) Enters Overbought Territory
08:35AM  The Advisory Board (ABCO) in Focus: Stock Surges 16.2%
08:30AM  Activist investor buys stake in The Advisory Board Co. at bizjournals.com
Jan-12-17 01:31PM  Activist Paul Singer's Pressure Boosts Advisory Board Stock +16.18%
12:07PM  Why The Advisory Board Company Stock Jumped Today at Motley Fool
Jan-10-17 10:24AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : January 10, 2017
Jan-09-17 07:17AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : January 9, 2017
Jan-06-17 10:02PM  Urban Institute to get 10 years of tax rebates after move to L'Enfant Plaza at bizjournals.com +6.44%
Jan-04-17 06:03AM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Di
Jan-03-17 04:50PM  The Advisory Board Company Aligns Health Care Capabilities to Enhance Efficiency and Drive Future Growth PR Newswire
Dec-21-16 05:00AM  Employers, Educators, Policymakers Collaborate to Outline Pathway to Middle Class through Health Care Careers PR Newswire
Dec-13-16 05:29PM  How D.C.'s West End stands to be impacted by Obama's post-presidency office plans at bizjournals.com
11:06AM  ETFs with exposure to The Advisory Board Co. : December 13, 2016
Dec-12-16 12:49PM  Hedge Funds Are Dumping The Advisory Board Company (ABCO) at Insider Monkey
09:20AM  Partnerships among Hospitals, Public Agencies, and Community-Based Organizations Can Improve Public Health PR Newswire
Nov-22-16 11:00AM  The Advisory Board Company to Participate in the Piper Jaffray Healthcare Conference on November 30, 2016 PR Newswire
Nov-18-16 12:54PM  ETFs with exposure to The Advisory Board Co. : November 18, 2016
Nov-17-16 01:04PM  ADVISORY BOARD CO Financials
12:41PM  Advisory Board Helps Hospitals, Health Systems Achieve more than $1.5 Billion ROI PR Newswire
10:37AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016
10:00AM  The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Nov-09-16 04:29PM  ADVISORY BOARD CO Files SEC form 10-Q, Quarterly Report
Nov-02-16 09:41AM  Four Universities Honored with National Awards for Advances in Student Success PR Newswire -8.19%
12:03AM  Edited Transcript of ABCO earnings conference call or presentation 1-Nov-16 9:30pm GMT
Nov-01-16 05:07PM  Advisory Board misses Street 3Q forecasts
05:04PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:10PM  The Advisory Board Company Reports Third Quarter Results PR Newswire
09:40AM  Top College Students Who Lose Small Amounts of Financial Aid More Likely to Drop Out PR Newswire
07:07AM  Q3 2016 Advisory Board Co Earnings Release - After Market Close
Oct-31-16 09:40AM  Medical Service Stock Earnings on Nov 1: ABCO, EVHC, HWAY
Oct-24-16 08:44AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : October 24, 2016
Oct-19-16 12:31PM  The incentive war: How Marriott's new deal stacks up at bizjournals.com
Oct-11-16 12:00PM  The Advisory Board Company to Report Third Quarter Financial Results After Market Close on November 1, 2016 PR Newswire
Oct-10-16 10:17AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : October 10, 2016
Oct-07-16 08:08AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : October 7, 2016
Sep-22-16 05:19PM  American CEOs sound off: What they would tell the next prez at bizjournals.com
Sep-16-16 10:09AM  Masimo PVI: Efficient Predictor for Fluid Optimization
Sep-13-16 04:15PM  The Advisory Board Company to Host Analyst and Investor Day September 26, 2016 PR Newswire
08:53AM  5 Medical Services Stocks to Buy Amid Healthcare Anxiety
08:15AM  NovoCure (NVCR) Worth Watching: Stock Jumps 6.6% in Session
Sep-08-16 01:34PM  The Advisory Board Company to Participate in Upcoming Conferences PR Newswire
Sep-07-16 10:21AM  HCA Holdings Boosts Patient Care; to Buy Mobile Heartbeat
Aug-29-16 04:03PM  The Advisory Board Company to Participate in Upcoming Conferences PR Newswire
09:26AM  INC Research Upgraded to Strong Buy on Estimate Revision
Aug-22-16 09:30AM  Zacks.com featured highlights: Coty, Advisory Board, Pan American Silver, Royal Gold and Cirrus Logic
Aug-19-16 09:57AM  5 Low Beta Stocks to Endure a Volatile Market
Aug-16-16 10:18AM  Why Civitas Solutions (CIVI) Could Be Positioned for a Slump
08:30AM  Strength Seen in Healthways Inc (HWAY): Stock Goes Up 7%
Aug-09-16 04:20PM  ADVISORY BOARD CO Files SEC form 10-Q, Quarterly Report
Aug-08-16 01:45PM  ETFs with exposure to The Advisory Board Co. : August 8, 2016
09:12AM  PAREXEL International (PRXL) Q4 Earnings Beat, Up Y/Y
Aug-05-16 10:38AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-03-16 02:56PM  Community Health (CYH) Lags Q2 Earnings, Stock Plunges
Aug-02-16 09:34AM  Will Advisory Board (ABCO) Continue to Surge Higher?
Jul-28-16 01:39AM  Edited Transcript of ABCO earnings conference call or presentation 27-Jul-16 9:30pm GMT +11.75%
Jul-27-16 04:46PM  Advisory Board beats Street 2Q forecasts
04:39PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  The Advisory Board Company Reports Results For Quarter Ended June 30, 2016 PR Newswire
07:07AM  Q1 2017 Advisory Board Co Earnings Release - After Market Close
Jul-26-16 09:53AM  Healthcare Q2 Earnings to Watch on Jul 27: ANTM, MOH & More
Jul-13-16 10:08AM  The Advisory Board Company Schedules Earnings Conference Call for the Quarter Ended June 30, 2016 PR Newswire
Jul-07-16 04:52PM  The Ensign Group (ENSG) Acquires Riverbend, Shares Up
Jun-28-16 10:05AM  Families Often Underestimate Financial Aid Eligibility PR Newswire
Jun-08-16 11:20AM  ADVISORY BOARD CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
10:05AM  The Advisory Board Company to Present at the William Blair 36th Annual Growth Stock Conference PR Newswire
May-31-16 09:15AM  Premarket Technical Breakdown Focuses on Key Business Services Stocks for Today
May-20-16 08:12AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : May 20, 2016
May-10-16 11:51AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 08:15AM  The Advisory Board Company (ABCO) Jumps: Stock Up 12.1%
May-06-16 03:11AM  Edited Transcript of ABCO earnings conference call or presentation 5-May-16 9:30pm GMT +12.10%
May-05-16 05:48PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
05:05PM  Advisory Board beats 1Q profit forecasts
04:30PM  The Advisory Board Company Reports Results For Quarter Ended March 31, 2016 PR Newswire
07:07AM  Q4 2016 Advisory Board Co Earnings Release - After Market Close
May-04-16 08:33AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : May 4, 2016
Apr-29-16 08:50AM  BioTelemetry (BEAT) in Focus: Stock Jumps 6.4% in Session Zacks
Apr-25-16 05:21PM  The Advisory Board Company Schedules Earnings Conference Call for the Quarter Ended March 31, 2016 PR Newswire
Apr-19-16 11:10AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : April 19, 2016
Apr-18-16 08:08AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : April 18, 2016
Apr-15-16 12:40PM  This Former Top Google Executive Is Joining an Investment Fund at Fortune
Apr-05-16 03:13PM  A peek inside The Advisory Board's planned new home at bizjournals.com
Apr-04-16 10:15AM  Survey Finds Hospital Executives Increasing Focus on Patient Expectations and Engagement PR Newswire
The Advisory Board Company provides best practices research and insight, performance technology software, consulting and management, and data-and tech-enabled services in the United States and internationally. Its best practices research and insight programs include published studies, executive education, proprietary databases and online services, access to experts, executive briefings, and other services. The company's best practices research and insight programs are focused on understanding industry dynamics, identifying best-demonstrated management practices, critically evaluating widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. It also offers cloud-based business intelligence and software applications that allow members to combine insights derived from best practices research with their operational and financial data to identify and assess revenue, cost-saving, or performance improvement opportunities; and consulting and management services that provide on-the-ground support for turnaround and performance improvement initiatives, as well as best practice and day-in-day-out professional management of the hospital or medical group areas. In addition, the company provides data- and tech-enabled services that optimize hospital and health system supply chain, as well as strategic, data-driven student engagement and enrollment management, financial aid optimization, and alumni fundraising solutions to the education industry. It offers its services through discrete programs to hospitals, health systems, independent medical groups, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care-focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miller Cormac FChief Product OfficerFeb 15Option Exercise16.5875012,43518,237Feb 17 01:46 PM
Miller Cormac FChief Product OfficerFeb 15Sale47.5075035,62517,487Feb 17 01:46 PM
Musslewhite Robert WChief Executive OfficerFeb 13Option Exercise16.585,50091,190260,811Feb 15 05:06 PM
Musslewhite Robert WChief Executive OfficerFeb 13Sale47.245,500259,820255,311Feb 15 05:06 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Option Exercise43.838,484371,85443,870Feb 08 08:50 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Sale46.848,484397,39135,386Feb 08 08:50 PM
Miller Cormac FChief Product OfficerFeb 01Option Exercise16.5875012,43518,237Feb 03 11:54 AM
Miller Cormac FChief Product OfficerFeb 01Sale45.8975034,41817,487Feb 03 11:54 AM
VAN HOOSE MARYChief Talent OfficerJan 19Option Exercise16.582,00033,16037,386Jan 20 04:57 PM
VAN HOOSE MARYChief Talent OfficerJan 19Sale41.442,00082,88035,386Jan 20 04:57 PM
Miller Cormac FChief Product OfficerJan 18Option Exercise16.5875012,43518,237Jan 20 11:46 AM
Miller Cormac FChief Product OfficerJan 18Sale40.5375030,39817,487Jan 20 11:46 AM
Musslewhite Robert WChief Executive OfficerJan 09Option Exercise16.585,50091,190260,811Jan 11 05:02 PM
Musslewhite Robert WChief Executive OfficerJan 09Sale35.765,500196,680255,311Jan 11 05:02 PM
Miller Cormac FChief Product OfficerJan 04Option Exercise16.5875012,43518,237Jan 09 06:01 AM
Miller Cormac FChief Product OfficerJan 04Sale32.6875024,50717,487Jan 09 06:01 AM
VAN HOOSE MARYChief Talent OfficerJan 03Option Exercise16.582,00033,16037,386Jan 04 10:39 AM
VAN HOOSE MARYChief Talent OfficerJan 03Sale33.492,00066,98035,386Jan 04 10:39 AM
Miller Cormac FChief Product OfficerDec 20Option Exercise16.5875012,43518,237Dec 22 07:35 PM
Kirshbaum Michael TChief Financial OfficerDec 20Option Exercise16.582,40039,79245,503Dec 22 07:51 PM
Kirshbaum Michael TChief Financial OfficerDec 20Sale32.922,40079,00843,103Dec 22 07:51 PM
Miller Cormac FChief Product OfficerDec 20Sale32.8575024,63817,487Dec 22 07:35 PM
VAN HOOSE MARYChief Talent OfficerDec 19Option Exercise16.582,00033,16037,386Dec 21 06:15 PM
VAN HOOSE MARYChief Talent OfficerDec 19Sale32.482,00064,96035,386Dec 21 06:15 PM
Musslewhite Robert WChief Executive OfficerDec 12Option Exercise16.585,50091,190259,084Dec 14 07:24 PM
Musslewhite Robert WChief Executive OfficerDec 12Sale33.875,500186,298255,311Dec 14 07:24 PM
Miller Cormac FChief Product OfficerDec 07Option Exercise16.5875012,43518,237Dec 09 08:39 AM
Miller Cormac FChief Product OfficerDec 07Sale32.5875024,43517,487Dec 09 08:39 AM
VAN HOOSE MARYChief Talent OfficerDec 06Option Exercise16.582,00033,16037,386Dec 08 08:04 PM
VAN HOOSE MARYChief Talent OfficerDec 06Sale31.982,00063,96035,386Dec 08 08:04 PM
Miller Cormac FChief Product OfficerNov 23Option Exercise16.5875012,43518,237Nov 29 10:25 AM
Miller Cormac FChief Product OfficerNov 23Sale36.7075027,52517,487Nov 29 10:25 AM
VAN HOOSE MARYChief Talent OfficerNov 22Option Exercise16.582,00033,16037,386Nov 23 12:44 PM
VAN HOOSE MARYChief Talent OfficerNov 22Sale36.982,00073,96035,386Nov 23 12:44 PM
Kirshbaum Michael TChief Financial OfficerNov 21Option Exercise16.582,40039,79245,503Nov 23 12:27 PM
Kirshbaum Michael TChief Financial OfficerNov 21Sale36.052,40086,52043,103Nov 23 12:27 PM
Musslewhite Robert WChief Executive OfficerNov 14Option Exercise16.585,50091,190260,811Nov 16 12:57 PM
Musslewhite Robert WChief Executive OfficerNov 14Sale32.885,500180,840255,311Nov 16 12:57 PM
VAN HOOSE MARYChief Talent OfficerNov 10Option Exercise16.582,00033,16037,386Nov 10 09:13 PM
VAN HOOSE MARYChief Talent OfficerNov 10Sale34.262,00068,52035,386Nov 10 09:13 PM
Miller Cormac FChief Product OfficerNov 09Option Exercise16.5875012,43518,237Nov 10 05:09 PM
Miller Cormac FChief Product OfficerNov 09Sale34.6375025,97317,487Nov 10 05:09 PM
Miller Cormac FChief Product OfficerOct 26Option Exercise16.5875012,43518,237Oct 28 01:15 PM
Miller Cormac FChief Product OfficerOct 26Sale41.6375031,22317,487Oct 28 01:15 PM
Kirshbaum Michael TChief Financial OfficerOct 20Option Exercise16.582,40039,79245,503Oct 24 09:20 PM
Kirshbaum Michael TChief Financial OfficerOct 20Sale42.802,400102,72043,103Oct 24 09:20 PM
Miller Cormac FChief Product OfficerOct 12Option Exercise16.5875012,43518,237Oct 14 03:49 PM
Miller Cormac FChief Product OfficerOct 12Sale43.1575032,36317,487Oct 14 03:49 PM
Musslewhite Robert WChief Executive OfficerOct 10Option Exercise16.585,50091,190260,811Oct 12 05:04 PM
Musslewhite Robert WChief Executive OfficerOct 10Sale43.895,500241,395255,311Oct 12 05:04 PM
ADVISORY BOARD CO10% OwnerSep 22Sale22.50317,7127,148,5204,128,167Sep 22 03:05 PM
Kirshbaum Michael TChief Financial OfficerSep 20Option Exercise16.582,40039,79245,503Sep 22 02:11 PM
Kirshbaum Michael TChief Financial OfficerSep 20Sale43.012,400103,22443,103Sep 22 02:11 PM
Miller Cormac FChief Product OfficerSep 14Option Exercise16.581,50024,87018,987Sep 16 04:36 PM
Miller Cormac FChief Product OfficerSep 14Sale43.041,50064,56017,487Sep 16 04:36 PM
ADVISORY BOARD CO10% OwnerSep 14Sale22.501,936,52943,571,9034,445,879Sep 14 05:00 PM
Musslewhite Robert WChief Executive OfficerSep 12Option Exercise16.585,50091,190260,811Sep 14 04:41 PM
Musslewhite Robert WChief Executive OfficerSep 12Sale43.095,500236,995255,311Sep 14 04:41 PM
Killefer NancyDirectorSep 06Option Exercise0.001,76606,667Sep 08 05:13 PM
Kirshbaum Michael TChief Financial OfficerAug 22Sale41.532,40099,67240,703Aug 24 04:47 PM
Farber Evan RChief Legal OfficerAug 17Sale40.952,924119,7380Aug 18 01:30 PM
GRUA PETER JDirectorAug 16Sale41.442,500103,60017,793Aug 18 05:02 PM
ZUMWALT LEANNE MDirectorAug 01Sale41.702,736114,09111,409Aug 03 02:24 PM
ZUMWALT LEANNE MDirectorJun 22Option Exercise0.002,79702,797Jun 24 03:49 PM
SHAPIRO LEONDirectorJun 22Option Exercise0.002,797014,793Jun 24 03:24 PM
Neaman Mark RDirectorJun 22Option Exercise0.002,797018,301Jun 24 03:14 PM
KINDICK KELTDirectorJun 22Option Exercise0.003,543026,205Jun 24 03:10 PM
Killefer NancyDirectorJun 22Option Exercise0.002,79704,901Jun 24 03:05 PM
GRUA PETER JDirectorJun 22Option Exercise0.002,797020,293Jun 24 03:01 PM
BANSAL SANJU KDirectorJun 22Option Exercise0.002,797066,064Jun 24 08:34 AM
KINDICK KELTDirectorMay 31Buy32.815,000164,05022,662Jun 01 03:26 PM
VAN HOOSE MARYChief Talent OfficerMay 10Option Exercise0.001,329035,826May 12 05:02 PM
Miller Cormac FChief Product OfficerMay 10Option Exercise0.0037903,622May 12 05:04 PM
Miller Cormac FChief Product OfficerMay 10Option Exercise0.001,541017,998May 12 05:04 PM
SCHWARTZ RICHARD AChief Operating OfficerMay 10Option Exercise0.001,539015,239May 12 05:01 PM
Farber Evan RChief Legal OfficerMay 10Option Exercise0.0098303,286May 12 04:58 PM
Kirshbaum Michael TChief Financial OfficerMay 10Option Exercise0.001,685043,715May 12 04:59 PM
FELSENTHAL DAVID LPresidentMay 10Option Exercise0.004,128054,623May 12 04:45 PM
Neaman Mark RDirectorApr 18Option Exercise0.002,508015,504Apr 19 09:19 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.0031103,284Apr 19 09:05 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.001,833017,064Apr 19 09:05 PM
FELSENTHAL DAVID LPresidentApr 18Option Exercise0.005,397052,282Apr 19 04:49 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 18Option Exercise0.001,833014,375Apr 19 04:47 PM
VAN HOOSE MARYChief Talent OfficerApr 18Option Exercise0.001,833035,104Apr 19 04:42 PM
Farber Evan RChief Legal OfficerApr 18Option Exercise0.001,22202,753Apr 19 04:40 PM
Kirshbaum Michael TChief Financial OfficerApr 18Option Exercise0.001,974042,747Apr 19 04:39 PM
Neaman Mark RDirectorApr 17Option Exercise0.002,736012,996Apr 19 09:19 PM
Miller Cormac FChief Product OfficerApr 17Option Exercise0.0031403,106Apr 19 09:05 PM
Miller Cormac FChief Product OfficerApr 17Option Exercise0.001,926015,869Apr 19 09:05 PM
FELSENTHAL DAVID LPresidentApr 17Option Exercise0.005,672048,763Apr 19 04:49 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 17Option Exercise0.002,002013,276Apr 19 04:47 PM
VAN HOOSE MARYChief Talent OfficerApr 17Option Exercise0.002,002033,934Apr 19 04:42 PM
Farber Evan RChief Legal OfficerApr 17Option Exercise0.001,33402,022Apr 19 04:40 PM
Kirshbaum Michael TChief Financial OfficerApr 17Option Exercise0.002,032041,511Apr 19 04:39 PM
Miller Cormac FChief Product OfficerApr 14Option Exercise24.231,62839,44615,571Apr 18 07:25 PM
Miller Cormac FChief Product OfficerApr 14Sale31.651,62851,52613,943Apr 18 07:25 PM
Miller Cormac FChief Product OfficerApr 11Option Exercise0.001,491014,437Apr 13 10:05 AM
VAN HOOSE MARYChief Talent OfficerApr 11Option Exercise0.001,459032,415Apr 12 03:52 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 11Option Exercise0.001,478011,815Apr 12 03:48 PM
Musslewhite Robert WChief Executive OfficerApr 11Option Exercise0.006,8480246,657Apr 12 03:42 PM